Participating Faculty

The American Journal of Managed Care

This supplement to includes information on the prevalence,cost of illness, and economic burden of chronic angina. This program has been peerreviewed by an expert in the field.

Faculty

Diana Frame, MEM

Director, Information Services

MetaWorks Inc

Medford, Massachusetts

Samuel George, MD

Director, Medical Affairs

CV Therapeutics, Inc

Palo Alto, California

George A. Goldberg, MD

Medical Director

Ingenix

Reston, Virginia

Mark A. Hlatky, MD

Professor of Health Research and

Policy and of Medicine

(Cardiovascular Medicine)

Stanford University School

of Medicine

Stanford, California

Mirou Jaana, PhD

Assistant Professor

Department of Health Management

and Policy

American University of Beirut

Beirut, Lebanon

Harold S. Javitz, PhD

Senior Statistician

Center for Health Sciences

SRI International

Menlo Park, California

Pam Kadlubek, MPH

Research Analyst

Ingenix

Reston, Virginia

Paul C. Nagle, BSBA

Partner

BioMedical Insights, Inc

San Francisco, California

John O. Parker, MD

Professor of Medicine

(Cardiology)

Department of Medicine

Queen's University

Associate Physician

Kingston General Hospital

Kingston, Ontario, Canada

Matthew W. Reynolds, PhD

Senior Director, Safety Services

MetaWorks Inc

Medford, Massachusetts

M. Evelyn Rose, PharmD

Associate Director of

eCommunications

CV Therapeutics, Inc

Palo Alto, California

Rachel Scheye, BA

Operations Manager

MetaWorks Inc

Medford, Massachusetts

Abigail W. Smith, BA

Research Analyst

BioMedical Insights, Inc

San Francisco, California

Marcia M. Ward, PhD

Assistant Professor

Department of Health Management

Policy

University of Iowa

Iowa City, Iowa

Jennifer B. Watson, PhD

Senior Manager, Scientific Marketing

CV Therapeutics, Inc

Palo Alto, California

Carol Zaher, MD, MBA, MPH

Senior Consultant

Ingenix

Reston, Virginia

Faculty Disclosure

The American Journal of Managed Care

It is the policy of to have all faculty who participate in programssponsored by corporate organizations disclose any real or apparent conflicts of interest.

The following participants report relationships with corporate organizations:

• Diana Frame, MEMResearch Support From:CV Therapeutics, Inc
• George A. Goldberg, MDResearch Support From:CV Therapeutics, Inc
• Mirou Jaana, PhDResearch Support From:CV Therapeutics, Inc
• Harold S. Javitz, PhDResearch Support From:CV Therapeutics, Inc
• Pam Kadlubek, MPHResearch Support From:CV Therapeutics, Inc
• Paul C. Nagle, BSBAResearch Support From:CV Therapeutics, Inc
• John O. Parker, MDResearch Support From and Consultant To:CV Therapeutics, IncAngiogenics Inc
• Matthew W. Reynolds, PhDResearch Support From:CV Therapeutics, Inc
• Rachel Scheye, BAResearch Support From:CV Therapeutics, Inc
• Abigail W. Smith, BAResearch Support From:CV Therapeutics, Inc
• Marcia M. Ward, PhDResearch Support From:CV Therapeutics, Inc
• Carol Zaher, MD, MBA, MPHResearch Support From:CV Therapeutics, IncConsultant To:Boehringer IngelheimPfizer Health SolutionsIngenixDistance Learning Network

The following participant reports no relationships with any corporations:

• Mark A. Hlatky, MD

The following participants are employees of CV Therapeutics, Inc:

• Samuel George, MD
• M. Evelyn Rose, PharmD
• Jennifer B. Watson, PhD

The American Journal of Managed Care

Signed disclosures are on file at the offices of , Jamesburg, New Jersey.

This program is being supported by an educational grant from CV Therapeutics, Inc.

The contents of this supplement may include information regarding the use of products that may be inconsistentwith or outside the approved labeling for these products in the United States. Physicians should note that theuse of these products outside current approved labeling is considered experimental and are advised to consultprescribing information for these products.

Download PDF: Participating Faculty